kabutan

Sumitomo Pharma Co., Ltd.(4506) Summary

4506
TSE Prime
Sumitomo Pharma Co., Ltd.
2,152.0
JPY
-111.0
(-4.90%)
Jan 29, 1:23 pm JST
14.07
USD
Jan 28, 11:24 pm EST
Result
PTS
outside of trading hours
2,155
Jan 29, 1:24 pm JST
Summary Chart Historical News Financial Result
PER
9.2
PBR
3.22
Yield
ー%
Margin Trading Ratio
4.82
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
2,220.0 JPY 14.49 USD
Previous Close Jan 28
2,263.0 JPY 14.82 USD
High Jan 29, 9:00 am
2,240.5 JPY 14.63 USD
Low Jan 29, 1:16 pm
2,142.0 JPY 13.99 USD
Volume
4,352,300
Trading Value
9.52B JPY 0.06B USD
VWAP
2188.14 JPY 14.3 USD
Minimum Trading Value
215,200 JPY 1,407 USD
Market Cap
0.86T JPY 5.60B USD
Number of Trades
13,196
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
11,662
1-Year High Nov 5, 2025
69,972
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 305,900 9,838,000 32.16
Jan 16, 2026 554,400 7,575,500 13.66
Jan 9, 2026 806,300 6,543,100 8.11
Dec 26, 2025 480,000 7,004,900 14.59
Dec 19, 2025 504,700 7,242,400 14.35
Company Profile
Sumitomo Pharma Co., Ltd. is a mid-sized pharmaceutical company originating from the Sumitomo Chemical group. The company focuses on developing drugs in the areas of psychiatry and neurology, oncology, and regenerative medicine.
Sector
Pharmaceuticals
Sumitomo Pharma's core business is the manufacturing, procurement, and sales of prescription pharmaceuticals, while also dealing with medical devices. The company prioritizes psychiatry, neurology, and oncology as its key therapeutic areas. In Japan, Sumitomo Pharma conducts manufacturing and sales of prescription pharmaceuticals through its subsidiaries. Additionally, through a joint venture with its parent company Sumitomo Chemical, it engages in contract development and manufacturing in the field of regenerative medicine and cell therapy. Sumitomo Pharma is also actively expanding globally, with operations in North America, China, Southeast Asia, and Taiwan. The company has established subsidiaries in various regions to conduct local pharmaceutical manufacturing, sales, and information provision activities.